Onzeald

etirinotecan pegol · Nektar Therapeutics UK Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Onzeald, covering 2018-02-02 to 2018-02-02. Get the full timeline:

Most recent: EMA Refused: Onzeald (etirinotecan pegol) — Nektar Therapeutics UK Limited